Home » Topics » BioWorld

BioWorld
RSS

FDA COMPLETES ONCOTRAC REVIEW

Jan. 22, 1992

TOCOR II OFFERING RAISES $90 MILLION

Jan. 22, 1992

IRELAND APPROVES ROBERTS CANCER TREATMENT

Jan. 21, 1992

CYTOGEN BEGINS THROMBOSCAN TRIALS

Jan. 21, 1992

GENENTECH SEEKS BUYER FOR PARTNERSHIP

Jan. 21, 1992

DEPRENYL USA RAISES $15 MILLION IN IPO

Jan. 21, 1992

TRANSGENIC MOUSE PRODUCES CF REGULATOR

Jan. 21, 1992

APPOINTMENTS AND ADVANCEMENTS

Jan. 20, 1992

IDEXX SETS PRICE FOR ACQUISITION

Jan. 20, 1992

ECOGEN PRIVATE PLACEMENT RAISES $8M

Jan. 20, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...